Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy.

J Transl Med · 2006 · PMC1513604 · PMID 16787540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Although interferon-alfa is still used in treatment of chronic viral hepatitis, its effect on the oxidant and antioxidant status of patients is not well known, which may be significant in deciding on the type on therapy, follow-up and prognosis of patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.